Klinische biologie avond

De onderzoeksprojecten van LHUB-ULB

• 18:30 · Introduction
  
  Olivier Vandenberg (LHUB-ULB - Academisch Verantwoordelijke)

• 18:35 · Development of a method for the quantitative determination of 8 anti-tuberculosis drugs by mass spectrometry: use for therapeutic monitoring and investigation of their protein binding
  
  David Fage (LHUB-ULB - Medische chemie)

• 18:55 · Molecular aspects of myeloid / lymphoid tumors with eosinophilia and associated with TK rearrangements
  
  Pierre Heimann (LHUB-ULB - Hematologie)

• 19:15 · Detection of Helicobacter pylori antigen in stool.  Comparative evaluation for optimization of routine analysis at LHUB-ULB
  
  Yvette Miendje & Rahinatou Garba (LHUB-ULB - Microbiologie)

• 19:35 · Prognostic factors for post-COVID-19 pulmonary fibrosis
  
  Nathalie De Vos (LHUB-ULB - Medische chemie)

• 19:55 · Conclusion
  
  Michel Toungouz (LHUB-ULB - Medisch Directeur)